ERBB2 and neoplasm: Nestin mRNA and the mRNA signature score also consistently showed higher expression in basal-like tumours, compared with HER2 enriched and luminal A and B subtypes (p-values < 0.0005 for most comparisons; for individual p-values, see Fig. 2 and Supplementary Fig. S1A and B).